Rivus Pharmaceuticals, Inc. Report issue

For profit Phase 2
Founded: Charlottesville VA United States (2019)

Organization Overview

First Clinical Trial
2020
NCT04463017
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2023

Timeline

NOW
  • Now

Alternative names

Rivus Pharmaceuticals, Inc.

Active Ingredients

Drugs in Phase 2 Trials (1)

hu6 (7 trials)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Fatty Liver (Phase 1)

Non-alcoholic Fatty Liver Disease (Phase 1)

Overview

  • Highest Phase: Phase 2
  • # of Trials: 7
  • # of Trial APIs: 1